TD Cowen flags margin pressure for CVS Health if Medicare Advantage star ratings lose momentum

CVS Health’s Medicare business is facing fresh scrutiny after TD Cowen warned that a setback in Medicare Advantage star ratings could translate into lower bottom-line results for the company. The concern centers on how many of CVS Health’s Medicare Advantage members sit in highly rated plans, a mix that can affect how much the plans are paid by the government.

In the discussion highlighted by Yahoo Finance, TD Cowen said CVS Health’s share of Medicare Advantage members in plans rated at least 4.5 stars is expected to fall sharply, to 35% from 63%. Medicare Advantage star ratings are a government scoring system that helps evaluate plan quality and performance, and the ratings can influence reimbursement levels and the commercial appeal of plans to beneficiaries and employers.

The downgrade in the projected mix matters because plans that score in the highest ranges generally carry more favorable reimbursement dynamics than lower-rated peers. TD Cowen’s framing, as presented in the report, is that a drop in the company’s highly rated member share could pressure CVS Health’s earnings power rather than simply affect plan marketing or enrollment.

The note also implicitly ties the issue to execution and year-over-year rating stability. Medicare Advantage star ratings are assessed annually, so changes in performance metrics, member experience measures, and other quality indicators can shift a plan’s rating tier. If CVS Health’s plans move down from higher star categories into lower ones, reimbursement and related economics can deteriorate.

CVS Health is one of the largest U.S. participants in Medicare Advantage through its health insurance offerings. The company’s broader strategy has long linked its retail presence with health services, including insurance coverage for seniors and other eligible populations. In that structure, changes in the Medicare insurance economics can become a key swing factor for overall results.

Sector-wide, analysts and investors often watch star ratings closely because they can change the pricing and profitability of Medicare Advantage products. A shift in member mix toward or away from top-rated plans can also affect how much competition intensifies in particular geographies and plan types, since better-rated products can be easier to defend on both marketing and economics.

That said, the information cited in the market report does not provide details on the specific drivers of the expected member share decline. It also does not spell out the precise timeframe of the forecast or whether TD Cowen’s view assumes a particular regulatory or reimbursement outcome beyond the rating mix itself. Investors would likely need more disclosure or follow-up research to understand the underlying assumptions and which plan measures are deteriorating.

For CVS Health, the near-term watch items are straightforward: whether its Medicare Advantage plan ratings stabilize, how quickly any rating slippage translates into membership mix, and whether management offers updated guidance on the impact to earnings. A clearer path for the company’s star ratings could help narrow the uncertainty that TD Cowen is indicating, while additional rating weakness would keep the pressure on the company’s bottom-line outlook.